 "Indian destocking hits GSK consumer health care business")
Two Indian-American brothers hailing from Gujarat, Chirag and Chintu Patel, have built a $1.8-billion drug major Amneal Pharmaceuticals in the US from scratch in around a decade and a half. After its recent merger with Impax Laboratories last month, the combined entity, with revenues of $1.75-1.85 billion, is close to pipping Indian giant Sun Pharmaceutical ($2 billion revenue in 2016-17) as the fifth-largest generics maker in the US. Amneal expects revenues to touch $2.6 billion by 2020.
The brothers, who spent the first two decades of their lives among a 45-member joint family in India, are, however, cautious about
